迷走神经刺激与儿童难治性癫痫发作结局:系统综述与meta分析
该系统综述与meta分析纳入101项研究,评估迷走神经刺激(VNS)作为儿童药物难治性癫痫(DRE)辅助治疗的疗效。末次随访(平均2.54年)时,50%应答率合并估计为56.4%(95%CI 52.4–60.4),无发作比例为11.6%(95%CI 9.6–13.9)。VNS前抗癫痫发作药物(ASM)试用种类较少及发作起病年龄较晚与更好的发作结局相关。
要点
- 儿童DRE中VNS辅助治疗的50%应答率合并估计为56.4%,完全无发作较少见(11.6%)。
- VNS前ASM试用种类较少与更好发作结局相关,早期转诊可能是可干预因素。
- 研究间性別分布对长期结局有影响,短期结局可能存在发表偏倚。
核心结论
- 汇总证据提示VNS对儿童药物难治性癫痫可能有效,但完全无发作并不常见。
- 从临床角度看,早期转诊(较少的ASM试用)可能是获得理想发作结局的可干预因素。
研究设计与样本
- 系统综述与meta分析,检索MEDLINE、EMBASE和Cochrane数据库至2019年7月,纳入儿童(≤18岁)癫痫VNS的原始研究。
- 共纳入101项研究,采用限制性最大似然估计的随机效应meta分析获得合并效应估计,并用多元线性模型meta回归分析结局决定因素与异质性来源。
主要发现
- 末次随访(平均2.54年)时,50%应答率合并患病率估计为56.4%(95%CI 52.4–60.4)。
- 末次随访时无发作比例合并估计为11.6%(95%CI 9.6–13.9)。
- VNS前试用ASM种类较少和发作起病年龄较晚与VNS植入后更好的发作结局相关。
- 观察到研究性別分布对长期结局有影响,短期结局存在潜在发表偏倚。
临床怎么用
- 对儿童药物难治性癫痫,VNS可作为辅助治疗选择,但应告知完全无发作比例较低。
- 在ASM试用种类较少时尽早转诊评估VNS,可能有助于改善发作结局。
局限性
- 短期结局存在潜在发表偏倚。
- 研究间存在异质性,性別分布等因素影响长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We synthesized evidence for effectiveness of vagus nerve stimulation (VNS) as adjuvant therapy in pediatric drug-resistant epilepsy (DRE) by obtaining pooled estimates for seizure outcomes and analyzing their determinants. METHODS: MEDLINE, EMBASE, and Cochrane databases were searched up to July 2019 for original research on VNS in pediatric (≤18 years of age) epilepsy. The primary outcome was 50% responder rate (50% RR), the proportion of patients with ≥50% seizure reduction, at the last reported follow-up. Other outcomes included a 50% RR and proportion of seizure-free patients at additional reported time points. A random-effects meta-analysis with restricted maximum likelihood estimation was performed to obtain pooled effect estimates. Meta-regression using multiple linear models was performed to obtain determinants of seizure outcomes and sources of heterogeneity. RESULTS: A total of 101 studies were included. The pooled prevalence estimates for a 50% RR and seizure freedom at last follow-up (mean 2.54 years) were 56.4% (95% confidence intervals [CIs] 52.4, 60.4) and 11.6% (95% CI 9.6, 13.9), respectively. Fewer antiseizure medications (ASMs) tried before VNS and later age at onset of seizures were associated with better seizure outcomes following VNS implantation. An effect of sex distribution of studies on long-term outcomes and a potential publication bias for short-term outcomes were also observed. CONCLUSION: Pooled evidence supports possible effectiveness of VNS in pediatric DRE, although complete seizure freedom is less common. Early referral (fewer trials of ASMs) may be a modifiable factor for desirable seizure outcomes with VNS from a clinical perspective.
引用
- Jain P, Arya R. Vagus Nerve Stimulation and Seizure Outcomes in Pediatric Refractory Epilepsy: Systematic Review and Meta-analysis. Neurology. 2021. PMID: 33849993. doi:10.1212/WNL.0000000000012030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。